207 related articles for article (PubMed ID: 17245342)
1. Increased expression of nucleophosmin/B23 in hepatocellular carcinoma and correlation with clinicopathological parameters.
Yun JP; Miao J; Chen GG; Tian QH; Zhang CQ; Xiang J; Fu J; Lai PB
Br J Cancer; 2007 Feb; 96(3):477-84. PubMed ID: 17245342
[TBL] [Abstract][Full Text] [Related]
2. [High expression of nucleophosmin/B23 in hepatocellular carcinoma].
Tian QH; Yun JP; Miao J; Chen G; Fu J; Zhang CQ; Su SG; Zhang MF; Wu QL
Zhonghua Bing Li Xue Za Zhi; 2006 Jul; 35(7):407-11. PubMed ID: 17069676
[TBL] [Abstract][Full Text] [Related]
3. The expression of beclin-1, an autophagic gene, in hepatocellular carcinoma associated with clinical pathological and prognostic significance.
Qiu DM; Wang GL; Chen L; Xu YY; He S; Cao XL; Qin J; Zhou JM; Zhang YX; E Q
BMC Cancer; 2014 May; 14():327. PubMed ID: 24885292
[TBL] [Abstract][Full Text] [Related]
4. Nucleophosmin/B23 promotes endometrial cancer cell escape from macrophage phagocytosis by increasing CD24 expression.
Lin CY; Tsai CL; Chao A; Lee LY; Chen WC; Tang YH; Chao AS; Lai CH
J Mol Med (Berl); 2021 Aug; 99(8):1125-1137. PubMed ID: 33954835
[TBL] [Abstract][Full Text] [Related]
5. Upregulation of B23 promotes tumor cell proliferation and predicts poor prognosis in glioma.
Chen J; Sun J; Yang L; Yan Y; Shi W; Shi J; Huang Q; Chen J; Lan Q
Biochem Biophys Res Commun; 2015 Oct; 466(1):124-30. PubMed ID: 26343305
[TBL] [Abstract][Full Text] [Related]
6. Phosphorylation of nucleophosmin at threonine 234/237 is associated with HCC metastasis.
Ching RH; Lau EY; Ling PM; Lee JM; Ma MK; Cheng BY; Lo RC; Ng IO; Lee TK
Oncotarget; 2015 Dec; 6(41):43483-95. PubMed ID: 26536659
[TBL] [Abstract][Full Text] [Related]
7. Clinical significance of nucleophosmin/B23 and human epidermal growth factor receptor 2/neu expressions in gastric cancers.
Zhou F; Qiu W; Sun L; Xiang J; Sun X; Sui A; Ding A; Yue L
APMIS; 2013 Jul; 121(7):582-91. PubMed ID: 23489260
[TBL] [Abstract][Full Text] [Related]
8. The clinical utility of the proliferating cell nuclear antigen expression in patients with hepatocellular carcinoma.
Ma S; Yang J; Li J; Song J
Tumour Biol; 2016 Jun; 37(6):7405-12. PubMed ID: 26676639
[TBL] [Abstract][Full Text] [Related]
9. A novel interaction of nucleophosmin with BCL2-associated X protein regulating death evasion and drug sensitivity in human hepatoma cells.
Lo SJ; Fan LC; Tsai YF; Lin KY; Huang HL; Wang TH; Liu H; Chen TC; Huang SF; Chang CJ; Lin YJ; Yung BY; Hsieh SY
Hepatology; 2013 May; 57(5):1893-905. PubMed ID: 23258611
[TBL] [Abstract][Full Text] [Related]
10. Immunohistochemical stains of proliferating cell nuclear antigen, insulin-like growth factor 2 and clusterin help distinguish malignant from benign liver nodular lesions.
Lai JP; Chen ZM; Lok T; Chan OT; Himmelfarb E; Zhai Q; Lin F; Wang HL
J Clin Pathol; 2014 Jun; 67(6):464-9. PubMed ID: 24407433
[TBL] [Abstract][Full Text] [Related]
11. The HBx oncoprotein of hepatitis B virus engages nucleophosmin to promote rDNA transcription and cellular proliferation.
Ahuja R; Kapoor NR; Kumar V
Biochim Biophys Acta; 2015 Aug; 1853(8):1783-95. PubMed ID: 25918010
[TBL] [Abstract][Full Text] [Related]
12. Involvement of nucleophosmin/B23 in the cellular response to curcumin.
Weng CH; Yung BY; Weng JJ; Wu MH
J Nutr Biochem; 2011 Jan; 22(1):46-52. PubMed ID: 20303727
[TBL] [Abstract][Full Text] [Related]
13. Neuron-glial antigen 2 overexpression in hepatocellular carcinoma predicts poor prognosis.
Lu LL; Sun J; Lai JJ; Jiang Y; Bai LH; Zhang LD
World J Gastroenterol; 2015 Jun; 21(21):6649-59. PubMed ID: 26074703
[TBL] [Abstract][Full Text] [Related]
14. Nucleophosmin and its complex network: a possible therapeutic target in hematological diseases.
Colombo E; Alcalay M; Pelicci PG
Oncogene; 2011 Jun; 30(23):2595-609. PubMed ID: 21278791
[TBL] [Abstract][Full Text] [Related]
15. Tissue hepatocyte growth factor and proliferating cell nuclear antigen in hepatocellular carcinoma.
Huang GT; Lee HS; Chen CH; Chiou LL; Lee CZ; Chen DS; Hsu HC; Sheu JC
J Formos Med Assoc; 1999 Feb; 98(2):92-6. PubMed ID: 10083763
[TBL] [Abstract][Full Text] [Related]
16. Nucleophosmin expression in renal cell carcinoma and oncocytoma.
Sari A; Calli A; Altinboga AA; Pehlivan FS; Gorgel SN; Balci U; Ermete M; Dincel C; Cakalagaoglu F
APMIS; 2012 Mar; 120(3):187-94. PubMed ID: 22339675
[TBL] [Abstract][Full Text] [Related]
17. Estrogen stimulates the proliferation of human endometrial cancer cells by stabilizing nucleophosmin/B23 (NPM/B23).
Chao A; Lin CY; Tsai CL; Hsueh S; Lin YY; Lin CT; Chou HH; Wang TH; Lai CH; Wang HS
J Mol Med (Berl); 2013 Feb; 91(2):249-59. PubMed ID: 22926011
[TBL] [Abstract][Full Text] [Related]
18. Nucleophosmin (NPM1/B23) interacts with activating transcription factor 5 (ATF5) protein and promotes proteasome- and caspase-dependent ATF5 degradation in hepatocellular carcinoma cells.
Liu X; Liu D; Qian D; Dai J; An Y; Jiang S; Stanley B; Yang J; Wang B; Liu X; Liu DX
J Biol Chem; 2012 Jun; 287(23):19599-609. PubMed ID: 22528486
[TBL] [Abstract][Full Text] [Related]
19. Relocation of NPM Affects the Malignant Phenotypes of Hepatoma SMMC-7721 Cells.
Li X; Xu DH; Liu F; Liu GY; Lu K; Deng XL; Li QF; Shi SL
J Cell Biochem; 2017 Oct; 118(10):3225-3236. PubMed ID: 28262969
[TBL] [Abstract][Full Text] [Related]
20. Characterization of centrosomal association of nucleophosmin/B23 linked to Crm1 activity.
Shinmura K; Tarapore P; Tokuyama Y; George KR; Fukasawa K
FEBS Lett; 2005 Dec; 579(29):6621-34. PubMed ID: 16297385
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]